can you give semaglutide in the thigh Ozempic Injection Sites: Abdomen vs vs Arm Thigh injections suck, lol, thought
Description
As mentioned above achieved weight loss, there is similarity to glucagon-like peptide-1 (GLP-1)
Cardiovascular Health: Studies suggest that semaglutide can lower the risk of major cardiovascular events, such as heart attack and stroke, in people with type 2 diabetes

Ozeki et al (2022) found that GLP1-RA semaglutide effectively reduces body adiposity while maintaining the skeletal muscle mass in obese Type 2 Diabetic patients. Xiang et al (2023) had similar findings, semaglutide can reduce the weight and fat of obese patients while effectively maintaining muscle mass and muscle strength. Chen et al (2023) conducted a 3-month intervention using dulaglutide in patients with Type 2 Diabetes, noting , dulaglutide intervention does not cause muscle and bone mass loss while inducing weight loss, and % change in body fat was independently associated with improved glucose control during dulaglutide therapy. With an increasing number of physicians and researchers relying on GLP-1 therapies for clinical care and research, it will continue to be crucial to track sensitive changes in body composition across different patient populations

Take the quiz here

Tirzepatide is administered as a once-weekly subcutaneous injection, with doses typically starting at 2.5 mg for initiation (not for glycemic control)